Status:
TERMINATED
A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension
Lead Sponsor:
Alcon Research
Conditions:
Open-Angle Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study was to assess the effects of total volume and total dose on the safety and intraocular pressure-lowering efficacy of Anecortave Acetate Suspension (3 mg and 48 mg) in 0.5 mL ...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Open-Angle Glaucoma or Ocular Hypertension for at least 6 months;
- Other protocol-defined inclusion criteria may apply.
Exclusion
- Prior angle surgery in the study eye, severe visual field loss in either eye;
- Other protocol-defined exclusion criteria may apply.
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
197 Patients enrolled
Trial Details
Trial ID
NCT00788541
Start Date
December 1 2008
End Date
September 1 2009
Last Update
November 30 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Contact Alcon Call Center For Trial Locations
Fort Worth, Texas, United States, 76134